Matches in Nanopublications for { ?s ?p "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP415390.RACLATQUtaJr0yl3euEWcQsadgXWNGIA5FiyrrSgpKrjQ130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415390.RACLATQUtaJr0yl3euEWcQsadgXWNGIA5FiyrrSgpKrjQ130_provenance.
- NP469529.RAl1N9nOjomEg2iRMKrB_liZrHT7NqPsEYCY59iZqc988130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469529.RAl1N9nOjomEg2iRMKrB_liZrHT7NqPsEYCY59iZqc988130_provenance.
- NP380280.RAl4OTe31nMyXLmSLH-CEbqrsZIsoqJ_VgzE5BWb0MMpI130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380280.RAl4OTe31nMyXLmSLH-CEbqrsZIsoqJ_VgzE5BWb0MMpI130_provenance.
- NP983343.RAV4xfutf-ZAQUAM20MPx8U7pLX0VD7lHIm7EdGEdOKm8130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983343.RAV4xfutf-ZAQUAM20MPx8U7pLX0VD7lHIm7EdGEdOKm8130_provenance.
- NP571677.RAQjFjXa_x_AKNhPGJ3tzwrB-Jo3WnhTDuBZw7Q5m2VpE130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571677.RAQjFjXa_x_AKNhPGJ3tzwrB-Jo3WnhTDuBZw7Q5m2VpE130_provenance.
- assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP983310.RAL6OmgbNtidmsquqnWRPHxHry0-dUTSX4gnHM3hvAZSc130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983310.RAL6OmgbNtidmsquqnWRPHxHry0-dUTSX4gnHM3hvAZSc130_provenance.
- NP983312.RAKqFaS1cbg0qhv8_lmliB-HCjMRUntBZXeWAKA8ZXjf0130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983312.RAKqFaS1cbg0qhv8_lmliB-HCjMRUntBZXeWAKA8ZXjf0130_provenance.
- NP571680.RAI9rAxt-RiKxEKoIte3CNA1WSBCrVvRMMJ7jlLXAXCzw130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571680.RAI9rAxt-RiKxEKoIte3CNA1WSBCrVvRMMJ7jlLXAXCzw130_provenance.
- NP571676.RAjhYSC8UZN1gs0FS-yvXM35dyMviph2kv2SGGJ7gnmvI130_assertion description "[This fact, combined with significant receptor expression in hepatitis virus-infected livers, suggests that IL-29 may have therapeutic value against chronic viral hepatitis in human patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571676.RAjhYSC8UZN1gs0FS-yvXM35dyMviph2kv2SGGJ7gnmvI130_provenance.